14 May

Credit Suisse Group Analysts Give Puma Biotechnology (NASDAQ:PBYI) a $106.00 Price Target

Credit Suisse Group set a $106.00 price objective on Puma Biotechnology (NASDAQ:PBYI) in a research report report published on Thursday, AprilĀ …

Leave a Reply